Published on 6 Apr 2024 on GuruFocus.com via Yahoo Finance
Jaume Pons, PRESIDENT & Chief Scientific Officer of ALX Oncology Holdings Inc (NASDAQ:ALXO), sold 20,000 shares of the company on April 4, 2024, according to a recent SEC Filing. The transaction was executed at an average price of $11.15 per share, resulting in a total value of $223,000.
Warning! GuruFocus has detected 2 Warning Signs with ALXO.